{arrow_up} Back to top

Risk Minimisation Materials

Search by company, common medicine name, or title of Risk Minimisation Material

Emtricitabine+Tenofovir

ADVANZ Pharma

{pdf_link}

Checklist for Prescribers v2 Tenofovir PrEP

{healthcare_pro_orange} For Healthcare Professionals
Checklist for Prescribers v2 Tenofovir PrEP

{pdf_link}

Important safety information for individuals using PrEP v2

{healthcare_pro_orange} For Healthcare Professionals
Important safety information for individuals using PrEP v2

{pdf_link}

Important safety information for prescribers v2 Tenofovir PrEP

{healthcare_pro_orange} For Healthcare Professionals
Important safety information for prescribers v2 Tenofovir PrEP

{pdf_link}

Reminder card v2 Tenofovir PrEP

{healthcare_pro_orange} For Healthcare Professionals
Reminder card v2 Tenofovir PrEP

{pdf_link}

Tenofovir HBV indications materials for children and adolescents

{healthcare_pro_orange} For Healthcare Professionals
Tenofovir HBV indications materials for children and adolescents

Amarox Limited

{pdf_link}

CHECKLIST FOR PRESCRIBERS

{healthcare_pro_orange} For Healthcare Professionals
CHECKLIST FOR PRESCRIBERS Initiation of emtricitabine/tenofovir disoproxil for Pre-Exposure Prophylaxis (PrEP)

{pdf_link}

EMTRICITABINE/ TENOFOVIR DISOPROXIL FOR PrEP REMINDER CARD

EMTRICITABINE/ TENOFOVIR DISOPROXIL FOR PrEP REMINDER CARD

{pdf_link}

IMPORTANT SAFETY INFORMATION For Prescribers

{healthcare_pro_orange} For Healthcare Professionals
IMPORTANT SAFETY INFORMATION For Prescribers About emtricitabine/ tenofovir disoproxil for a Pre-Exposure Prophylaxis (PrEP) Indication

{pdf_link}

Information for individuals

IMPORTANT INFORMATION ABOUT EMTRICITABINE/TENOFOVIR DISOPROXIL TO REDUCE THE RISK OF GETTING HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION Information for individuals who have been prescribed emtricitabine/ tenofovir disoproxil for Pre-Exposure Prophylaxis (PrEP)

Aurobindo Pharma - Milpharm Ltd.

{pdf_link}

Emtricitabine-Tenofovir Checklist for Prescribers

{healthcare_pro_orange} For Healthcare Professionals
Emtricitabine-Tenofovir Checklist for Prescribers-v2.0

{pdf_link}

Emtricitabine-Tenofovir Important educational information for Patients

{healthcare_pro_orange} For Healthcare Professionals
Important educational information for Patients

{pdf_link}

Emtricitabine-Tenofovir Important safety information for prescribers

{healthcare_pro_orange} For Healthcare Professionals
Important safety information for prescribers-v2.0

{pdf_link}

Emtricitabine-Tenofovir Patient Reminder card

{healthcare_pro_orange} For Healthcare Professionals
Patient Reminder card-v2.0

Dr. Reddy's Laboratories (UK) Ltd

{pdf_link}

Checklist for Prescribers v2 Tenofovir PrEP

{healthcare_pro_orange} For Healthcare Professionals
Initiation of emtricitabine/tenofovir disoproxil for Pre-Exposure Prophylaxis (PrEP) Complete checklist at each visit and file in individuals medical record.

{pdf_link}

Emtricitabine/Tenofovir disoproxil Dr. Reddy's 200 mg/245 mg Film-Coated Tablets

{healthcare_pro_orange} For Healthcare Professionals
Renal and bone effects risk minimisation material: Tenofovir disoproxil for children and adolescents with HIV-1

{pdf_link}

Important Information about Emtricitabine/Tenofovir Disoproxil To Reduce The Risk Of Getting Human Immunodeficiency Virus (HIV) Infection

Information for individuals who have been prescribed emtricitabine/tenofovir disoproxil for Pre-Exposure Prophylaxis (PrEP)

{pdf_link}

Important Safety Information for prescribers v2 Tenofovir PrEP

{healthcare_pro_orange} For Healthcare Professionals
Emtricitabine/ tenofovir disoproxil is indicated in combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in adults at high risk. This indication is based on clinical trials in men who have sex with men (MSM) at high risk for HIV-1 infection and on men and women in heterosexual serodiscordant couples.

{pdf_link}

Reminder Card v2 Tenofovir PrEP

You have been prescribed emtricitabine/ tenofovir disoproxil for PrEP (pre-exposure prophylaxis) to help reduce the risk of getting HIV-1 infection. For this medicine to work effectively it is important that you don’t miss doses. The recommended dose is one emtricitabine/ tenofovir disoproxil tablet each day. Take emtricitabine/ tenofovir disoproxil exactly as your doctor has told you.

Lupin Healthcare (UK) Ltd

{pdf_link}

Checklist for Prescribers

{healthcare_pro_orange} For Healthcare Professionals
Initiation of emtricitabine/tenofovir disoproxil for Pre-Exposure Prophylaxis (PrEP)

{pdf_link}

Important Information about Emticitabine/Tenofovir Disproxil

{healthcare_pro_orange} For Healthcare Professionals
Information for individuals who have been prescribed emtricitabine/ tenofovir disoproxil for Pre-Exposure Prophylaxis (PrEP)

{pdf_link}

Important Safety Information for Prescribers

{healthcare_pro_orange} For Healthcare Professionals
For Prescribers About emtricitabine/ tenofovir disoproxil for a Pre-Exposure Prophylaxis (PrEP) Indication

{pdf_link}

Reminder Card

{healthcare_pro_orange} For Healthcare Professionals
EMTRICITABINE/ TENOFOVIR DISOPROXIL FOR PrEP REMINDER CARD

Mylan

{pdf_link}

Emtricitabine/Tenofovir disoproxil Checklist for Prescribers

{healthcare_pro_orange} For Healthcare Professionals
Emtricitabine/Tenofovir disoproxil Checklist for Prescribers PrEP

{pdf_link}

Emtricitabine/Tenofovir Disoproxil Patient Brochure

Patient Brochure for Emtricitabine/Tenofovir disoproxil for PrEP (pre-exposure prophylaxis)

{pdf_link}

Emtricitabine/Tenofovir Disoproxil Prescriber's Brochure

{healthcare_pro_orange} For Healthcare Professionals
Important Safety Information for Prescribers About Emtricitabine/Tenofovir Disoproxil for a Pre-exposure Prophylaxis (PrEP) Indication

{pdf_link}

Patient Reminder Card for Emtricitabine/Tenofovir Disoproxil

Patient Reminder Card for Emtricitabine/Tenofovir disoproxil for PrEP (pre-exposure prophylaxis).

Tillomed Laboratories Ltd

{pdf_link}

Checklist for Prescribers

{healthcare_pro_orange} For Healthcare Professionals
Checklist for Prescribers

{pdf_link}

Important educational information for patients

Information for individuals who have been prescribed emtricitabine/ tenofovir disoproxil for Pre-Exposure Prophylaxis (PrEP)

{pdf_link}

Important safety information for prescribers

{healthcare_pro_orange} For Healthcare Professionals
For Prescribers About emtricitabine/ tenofovir disoproxil for a Pre-Exposure Prophylaxis (PrEP) Indication

{pdf_link}

Patient reminder card

EMTRICITABINE/ TENOFOVIR DISOPROXIL FOR PrEP REMINDER CARD

Tenofovir

Aristo Pharma Limited

{pdf_link}

Tenofovir disoproxil for adolescent children with chronic hepatitis B

{healthcare_pro_orange} For Healthcare Professionals
Renal risk minimisation material: Tenofovir disoproxil for adolescent children with chronic hepatitis B

{pdf_link}

Tenofovir disoproxil for children and adolescents with HIV-1

{healthcare_pro_orange} For Healthcare Professionals
Renal and bone effects risk minimisation material: Tenofovir disoproxil for children and adolescents with HIV-1

Cipla EU Ltd

{pdf_link}

Educational Material: TENOFOVIR DISOPROXIL FOR ADOLESCENT CHILDREN WITH CHRONIC HEPATITIS B

{healthcare_pro_orange} For Healthcare Professionals
RENAL RISK MINIMISATION MATERIAL: TENOFOVIR DISOPROXIL FOR ADOLESCENT CHILDREN WITH CHRONIC HEPATITIS B

{pdf_link}

Educational material: TENOFOVIR DISOPROXIL FOR CHILDREN AND ADOLESCENTS WITH HIV-1

{healthcare_pro_orange} For Healthcare Professionals
RENAL AND BONE EFFECTS RISK MINIMISATION MATERIAL: TENOFOVIR DISOPROXIL FOR CHILDREN AND ADOLESCENTS WITH HIV-1

Dr. Reddy's Laboratories (UK) Ltd

{pdf_link}

Renal and Bone Effects Risk Minimisation Material: Tenofovir Disoproxil for Children and Adolescents with HIV-1

{healthcare_pro_orange} For Healthcare Professionals
HIV-1 Renal & bone effects education brochure - children

{pdf_link}

Renal Risk Minimisation Material Tenofovir Disoproxil for Adolescent Children with Chronic Hepatitis B

{healthcare_pro_orange} For Healthcare Professionals
HBV renal education brochure - children

Sandoz Limited

{pdf_link}

Renal and bone effects risk minimisation material: Tenofovir disoproxil for children and adolescents with HIV-1

{healthcare_pro_orange} For Healthcare Professionals
This brochure provides important advice on the management of potential renal and bone effects of tenofovir disoproxil in HIV-1 infected children and adolescents aged 2 to <18 years, and on the dosing recommendations for tenofovir disoproxil in this population.

{pdf_link}

Renal Risk Minimisation Material: Tenofovir Disoproxil for adolescent children with chronic hepatitis B

{healthcare_pro_orange} For Healthcare Professionals
This brochure provides important advice on the management of potential renal and bone effects of tenofovir disoproxil in adolescent patients with chronic hepatitis B aged 12 to <18 years, and on the dosing recommendations for tenofovir disoproxil in this population.

{pdf_link}

TENOFOVIR DISOPROXIL FOR ADULTS WITH CHRONIC HEPATITIS B

RENAL RISK MINIMISATION MATERIAL: TENOFOVIR DISOPROXIL FOR ADULTS WITH CHRONIC HEPATITIS B

Truvada

Gilead Sciences Ltd

{pdf_link}

Truvada 200 mg/245 mg film-coated tablets (emtricitabine/tenofovir disoproxil fumarate) - PrEP Educational Materials - Checklist For Prescribers

{healthcare_pro_orange} For Healthcare Professionals
Checklist For Prescribers from the Physician educational pack for Truvada® (emtricitabine 200mg/ tenofovir disoproxil fumarate 245mg) for pre-exposure prophylaxis (PrEP) in patients at risk of sexually acquired HIV-1 infection

{pdf_link}

Truvada 200 mg/245 mg film-coated tablets (emtricitabine/tenofovir disoproxil fumarate) - PrEP Educational Materials - Patient Leaflet

Patient Leaflet from the Physician educational pack for Truvada® (emtricitabine 200mg/ tenofovir disoproxil fumarate 245mg) for pre-exposure prophylaxis (PrEP) in patients at risk of sexually acquired HIV-1 infection. It contains Important Information About Truvada® (emtricitabine/tenofovir disoproxil fumarate) to Reduce the Risk of Getting Human Immunodeficiency Virus (HIV) Infection for individuals who have been prescribed Truvada® for Pre-Exposure Prophylaxis (PrEP)

{pdf_link}

Truvada 200 mg/245 mg film-coated tablets (emtricitabine/tenofovir disoproxil fumarate) - PrEP Educational Materials - Prescribers Leaflet

{healthcare_pro_orange} For Healthcare Professionals
Important Safety Information for Prescribers About Truvada® (emtricitabine/tenofovir disoproxil fumarate) for a Pre-exposure Prophylaxis (PrEP) Indication

{pdf_link}

Truvada 200 mg/245 mg film-coated tablets (emtricitabine/tenofovir disoproxil fumarate) - PrEP Educational Materials - Reminder Card

Reminder Card for patients from the Physician educational pack for Truvada® (emtricitabine 200mg/ tenofovir disoproxil fumarate 245mg) for pre-exposure prophylaxis (PrEP) in patients at risk of sexually acquired HIV-1 infection.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?